Eaton Vance Management Teva Pharmaceutical Industries LTD Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

A detailed history of Eaton Vance Management transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eaton Vance Management holds 17,944 shares of TEVA stock, worth $307,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,944
Previous 17,910 0.19%
Holding current value
$307,201
Previous $134,000 8.21%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $233 - $406
34 Added 0.19%
17,944 $145,000
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $31,800 - $44,813
4,309 Added 31.68%
17,910 $134,000
Q1 2022

May 16, 2022
BUY
$7.33 - $9.39 $1,832 - $2,347
250 Added 1.87%
13,601 $127,000
Q3 2021

Nov 15, 2021
SELL
$8.38 - $10.18 $64,174 - $77,958
-7,658 Reduced 36.45%
13,351 $88,000
Q2 2021

Aug 16, 2021
BUY
$9.9 - $11.56 $30,561 - $35,685
3,087 Added 17.22%
21,009 $208,000
Q1 2021

May 17, 2021
SELL
$10.34 - $12.81 $18,188 - $22,532
-1,759 Reduced 8.94%
17,922 $207,000
Q4 2020

Feb 12, 2021
SELL
$8.61 - $11.04 $185,855 - $238,309
-21,586 Reduced 52.31%
19,681 $190,000
Q3 2020

Nov 13, 2020
SELL
$8.57 - $12.69 $326,337 - $483,222
-38,079 Reduced 47.99%
41,267 $372,000
Q2 2020

Aug 13, 2020
SELL
$8.12 - $13.12 $3.46 Million - $5.59 Million
-426,190 Reduced 84.3%
79,346 $978,000
Q1 2020

May 14, 2020
SELL
$6.69 - $13.45 $591,630 - $1.19 Million
-88,435 Reduced 14.89%
505,536 $4.54 Million
Q4 2019

Feb 11, 2020
SELL
$6.53 - $10.72 $37,612 - $61,747
-5,760 Reduced 0.96%
593,971 $5.82 Million
Q3 2019

Nov 14, 2019
SELL
$6.16 - $9.6 $876,019 - $1.37 Million
-142,211 Reduced 19.17%
599,731 $4.13 Million
Q2 2019

Aug 16, 2019
SELL
$8.12 - $15.72 $431,001 - $834,401
-53,079 Reduced 6.68%
741,942 $6.85 Million
Q1 2019

May 14, 2019
SELL
$15.58 - $20.01 $8,833 - $11,345
-567 Reduced 0.07%
795,021 $12.5 Million
Q4 2018

Feb 07, 2019
SELL
$14.59 - $23.84 $13.1 Million - $21.4 Million
-896,366 Reduced 52.98%
795,588 $12.3 Million
Q3 2018

Nov 13, 2018
SELL
$21.06 - $25.65 $20,575 - $25,060
-977 Reduced 0.06%
1,691,954 $36.4 Million
Q2 2018

Aug 10, 2018
SELL
$16.77 - $24.71 $11,806 - $17,395
-704 Reduced 0.04%
1,692,931 $41.2 Million
Q1 2018

May 07, 2018
BUY
$16.68 - $22.07 $17,564 - $23,239
1,053 Added 0.06%
1,693,635 $28.9 Million
Q4 2017

Feb 12, 2018
SELL
$11.23 - $19.1 $699,730 - $1.19 Million
-62,309 Reduced 3.55%
1,692,582 $32.1 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $27 Million - $56.5 Million
1,754,891
1,754,891 $30.9 Million

Others Institutions Holding TEVA

# of Institutions
624
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email